- Home
- MTVA vs INLF Comparison
MTVA vs INLF Comparison
Compare MTVA & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- INLF
- Stock Information
- Founded
- MTVA 2014
- INLF 2016
- Country
- MTVA United States
- INLF China
- Employees
- MTVA N/A
- INLF N/A
- Industry
- MTVA
- INLF Industrial Machinery/Components
- Sector
- MTVA
- INLF Industrials
- Exchange
- MTVA NYSE
- INLF Nasdaq
- Market Cap
- MTVA 15.1M
- INLF 18.1M
- IPO Year
- MTVA N/A
- INLF 2025
- Fundamental
- Price
- MTVA $0.69
- INLF $1.13
- Analyst Decision
- MTVA Strong Buy
- INLF
- Analyst Count
- MTVA 2
- INLF 0
- Target Price
- MTVA $7.50
- INLF N/A
- AVG Volume (30 Days)
- MTVA 599.8K
- INLF 47.9K
- Earning Date
- MTVA 05-14-2025
- INLF 01-01-0001
- Dividend Yield
- MTVA N/A
- INLF N/A
- EPS Growth
- MTVA N/A
- INLF 18.78
- EPS
- MTVA N/A
- INLF 0.13
- Revenue
- MTVA N/A
- INLF $15,796,983.00
- Revenue This Year
- MTVA N/A
- INLF N/A
- Revenue Next Year
- MTVA N/A
- INLF N/A
- P/E Ratio
- MTVA N/A
- INLF $8.95
- Revenue Growth
- MTVA N/A
- INLF 25.27
- 52 Week Low
- MTVA $0.63
- INLF $1.09
- 52 Week High
- MTVA $5.30
- INLF $21.00
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- INLF N/A
- Support Level
- MTVA N/A
- INLF N/A
- Resistance Level
- MTVA N/A
- INLF N/A
- Average True Range (ATR)
- MTVA 0.00
- INLF 0.00
- MACD
- MTVA 0.00
- INLF 0.00
- Stochastic Oscillator
- MTVA 0.00
- INLF 0.00
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd is a holding company and does business through its subsidiary. It is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.